Quest PharmaTech Inc
Research Quest PharmaTech Inc (QPT) on Bullrun: market cap CAD 5.07M, P/E 0.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerQPT
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 5.07M
- P/E0.8
- Financial periodQ1 2026
- RevenueCAD 0
- Net incomeCAD 3.40M
- Free cash flow-CAD 43.88K
Valuation Snapshot
latest market cap is CAD 5.07M; P/E is 0.8.
Peer valuation comparison
Latest P/E is 0.83x versus a Healthcare sector median of 24.46x (96.6% below).
Latest P/E is 0.83x versus a Canada median of 15.58x (94.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | CAD 5.07M | 0.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Quest PharmaTech Inc
Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Quest PharmaTech Inc's market cap?
Quest PharmaTech Inc's market capitalization is CAD 5.07M.
What is Quest PharmaTech Inc's P/E ratio?
Quest PharmaTech Inc's price-to-earnings (P/E) ratio is 0.8.
What does Quest PharmaTech Inc do?
Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.